Antiplatelet therapy for thromboprophylaxis: the need for careful consideration of the evidence from randomised trials
Identifieur interne : 002D01 ( Main/Curation ); précédent : 002D00; suivant : 002D02Antiplatelet therapy for thromboprophylaxis: the need for careful consideration of the evidence from randomised trials
Auteurs : R. Collins ; C. Baignent ; P. Sandercock ; R. PetoSource :
- BMJ [ 0959-8138 ] ; 1994-11-05.
English descriptors
- Teeft :
- Acetylsalicylic acid, Antiplatelet, Antiplatelet prophylaxis, Antiplatelet therapy, Antiplatelet trialists, Aspirin, Collaborative overview, Deep vein thrombosis, Deep venous thrombosis, Dose heparin, Embolism, Heparin, High risk, Medical patients, Orthopaedic, Overview, Placebo, Prophylaxis, Proportional reductions, Pulmonary emboli, Pulmonary embolism, Randomised, Randomised trials, Standard heparin, Subcutaneous, Subcutaneous heparin, Surgical, Surgical patients, Thromboembolism, Thromboprophylaxis, Thrombosis, Trialists, Venous, Venous thromboembolism, Venous thrombosis.
Url:
DOI: 10.1136/bmj.309.6963.1215
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: Pour aller vers cette notice dans l'étape Curation :002426
- to stream Istex, to step Curation: Pour aller vers cette notice dans l'étape Curation :002426
- to stream Istex, to step Checkpoint: Pour aller vers cette notice dans l'étape Curation :001A86
- to stream Main, to step Merge: Pour aller vers cette notice dans l'étape Curation :002D61
Links to Exploration step
ISTEX:E37E882E67DD6D60291CC653C764A936D0011DB6Curation
No country items
R. Collins<affiliation><wicri:noCountry code="subField">2XU</wicri:noCountry>
</affiliation>
<affiliation><wicri:noCountry code="subField">2XU</wicri:noCountry>
</affiliation>
<affiliation><wicri:noCountry code="subField">2XU</wicri:noCountry>
</affiliation>
<affiliation><wicri:noCountry code="subField">2XU</wicri:noCountry>
</affiliation>
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Antiplatelet therapy for thromboprophylaxis: the need for careful consideration of the evidence from randomised trials</title>
<author><name sortKey="Collins, R" sort="Collins, R" uniqKey="Collins R" first="R" last="Collins">R. Collins</name>
</author>
<author><name sortKey="Baignent, C" sort="Baignent, C" uniqKey="Baignent C" first="C" last="Baignent">C. Baignent</name>
</author>
<author><name sortKey="Sandercock, P" sort="Sandercock, P" uniqKey="Sandercock P" first="P" last="Sandercock">P. Sandercock</name>
</author>
<author><name sortKey="Peto, R" sort="Peto, R" uniqKey="Peto R" first="R" last="Peto">R. Peto</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:E37E882E67DD6D60291CC653C764A936D0011DB6</idno>
<date when="1994" year="1994">1994</date>
<idno type="doi">10.1136/bmj.309.6963.1215</idno>
<idno type="url">https://api.istex.fr/ark:/67375/NVC-J9N203JR-B/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">002426</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">002426</idno>
<idno type="wicri:Area/Istex/Curation">002426</idno>
<idno type="wicri:Area/Istex/Checkpoint">001A86</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">001A86</idno>
<idno type="wicri:doubleKey">0959-8138:1994:Collins R:antiplatelet:therapy:for</idno>
<idno type="wicri:Area/Main/Merge">002D61</idno>
<idno type="wicri:Area/Main/Curation">002D01</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Antiplatelet therapy for thromboprophylaxis: the need for careful consideration of the evidence from randomised trials</title>
<author><name sortKey="Collins, R" sort="Collins, R" uniqKey="Collins R" first="R" last="Collins">R. Collins</name>
<affiliation><wicri:noCountry code="subField">2XU</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Baignent, C" sort="Baignent, C" uniqKey="Baignent C" first="C" last="Baignent">C. Baignent</name>
<affiliation><wicri:noCountry code="subField">2XU</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Sandercock, P" sort="Sandercock, P" uniqKey="Sandercock P" first="P" last="Sandercock">P. Sandercock</name>
<affiliation><wicri:noCountry code="subField">2XU</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Peto, R" sort="Peto, R" uniqKey="Peto R" first="R" last="Peto">R. Peto</name>
<affiliation><wicri:noCountry code="subField">2XU</wicri:noCountry>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">BMJ</title>
<title level="j" type="abbrev">BMJ</title>
<idno type="ISSN">0959-8138</idno>
<idno type="eISSN">1468-5833</idno>
<imprint><publisher>British Medical Journal Publishing Group</publisher>
<date type="published" when="1994-11-05">1994-11-05</date>
<biblScope unit="volume">309</biblScope>
<biblScope unit="issue">6963</biblScope>
<biblScope unit="page" from="1215">1215</biblScope>
</imprint>
<idno type="ISSN">0959-8138</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0959-8138</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="Teeft" xml:lang="en"><term>Acetylsalicylic acid</term>
<term>Antiplatelet</term>
<term>Antiplatelet prophylaxis</term>
<term>Antiplatelet therapy</term>
<term>Antiplatelet trialists</term>
<term>Aspirin</term>
<term>Collaborative overview</term>
<term>Deep vein thrombosis</term>
<term>Deep venous thrombosis</term>
<term>Dose heparin</term>
<term>Embolism</term>
<term>Heparin</term>
<term>High risk</term>
<term>Medical patients</term>
<term>Orthopaedic</term>
<term>Overview</term>
<term>Placebo</term>
<term>Prophylaxis</term>
<term>Proportional reductions</term>
<term>Pulmonary emboli</term>
<term>Pulmonary embolism</term>
<term>Randomised</term>
<term>Randomised trials</term>
<term>Standard heparin</term>
<term>Subcutaneous</term>
<term>Subcutaneous heparin</term>
<term>Surgical</term>
<term>Surgical patients</term>
<term>Thromboembolism</term>
<term>Thromboprophylaxis</term>
<term>Thrombosis</term>
<term>Trialists</term>
<term>Venous</term>
<term>Venous thromboembolism</term>
<term>Venous thrombosis</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
</TEI>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Main/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002D01 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Curation/biblio.hfd -nk 002D01 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= ChloroquineV1 |flux= Main |étape= Curation |type= RBID |clé= ISTEX:E37E882E67DD6D60291CC653C764A936D0011DB6 |texte= Antiplatelet therapy for thromboprophylaxis: the need for careful consideration of the evidence from randomised trials }}
This area was generated with Dilib version V0.6.33. |